Terms: = Lung cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1
297 results:
1. [A clinical-radiomics nomogram for differentiating focal organizing pneumonia and lung adenocarcinoma].
Liu Y; Li C; Guo J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):397-404. PubMed ID: 38501426
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Histone Lysine Methyltransferase SUV4-20H2 on cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract] [Full Text] [Related]
3. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer.
Choi YJ; Choi M; Park J; Park M; Kim MJ; Lee JS; Oh SJ; Lee YJ; Shim WS; Kim JW; Kim MJ; Kim YC; Kang KW
Biomed Pharmacother; 2024 Feb; 171():116124. PubMed ID: 38198957
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of 4-((3,4-dichlorophenyl)amino)-2-methylquinolin-6-ol derivatives as EGFR and HDAC dual inhibitors.
Qian Y; Zhou S; Li J; Ma M; Chen H; Cao Y; Zhang Y; Sun C; Li K; Liu Y; Dai S; Ao M; Fang M; Wu Z; Li M
Eur J Pharmacol; 2023 Dec; 960():176114. PubMed ID: 37863412
[TBL] [Abstract] [Full Text] [Related]
6. Discovery, validation, and prodrug design of an ACE2 activator for treating bacterial infection-induced lung inflammation.
Lu P; Leslie F; Wang H; Sodhi A; Choi CY; Pekosz A; Cui H; Jia H
J Control Release; 2023 Dec; 364():1-11. PubMed ID: 37858626
[TBL] [Abstract] [Full Text] [Related]
7. An Investigation of the Effects of
Jin YC; Dong LJ; Yang QY; Xiong WN; Wang WY; Feng XH; Yu W; Huang W; Chen BF
Biomed Environ Sci; 2023 Sep; 36(9):814-825. PubMed ID: 37803894
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor.
Sawant M; Wilson A; Sridaran D; Mahajan K; O'Conor CJ; Hagemann IS; Luo J; Weimholt C; Li T; Roa JC; Pandey A; Wu X; Mahajan NP
Oncogene; 2023 Jul; 42(29):2263-2277. PubMed ID: 37330596
[TBL] [Abstract] [Full Text] [Related]
9. Intracranial Activity of Selpercatinib in Chinese Patients With Advanced
Cheng Y; Huang D; Zhou J; Zhou C; Sun Y; Wu L; Guo Y; Jingxin S; Zhang W; Lu S
JCO Precis Oncol; 2023 Jun; 7():e2200708. PubMed ID: 37315261
[TBL] [Abstract] [Full Text] [Related]
10. Establishment and visualization of a model based on high-resolution CT qualitative and quantitative features for prediction of micropapillary or solid components in invasive lung adenocarcinoma.
Dong H; Wang X; Qiu Y; Lou C; Ye Y; Feng H; Ye X; Chen D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10519-10530. PubMed ID: 37289235
[TBL] [Abstract] [Full Text] [Related]
11. First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.
Fiorentino F; Sementilli S; Menna M; Turrisi F; Tomassi S; Pellegrini FR; Iuzzolino A; D'Acunzo F; Feoli A; Wapenaar H; Taraglio S; Fraschetti C; Del Bufalo D; Sbardella G; Dekker FJ; Paiardini A; Trisciuoglio D; Mai A; Rotili D
J Med Chem; 2023 May; 66(10):6591-6616. PubMed ID: 37155735
[TBL] [Abstract] [Full Text] [Related]
12. Human cancer Cell Radiation Response Investigated through Topological Analysis of 2D Cell Networks.
Tirinato L; Onesto V; Garcia-Calderon D; Pagliari F; Spadea MF; Seco J; Gentile F
Ann Biomed Eng; 2023 Aug; 51(8):1859-1871. PubMed ID: 37093401
[TBL] [Abstract] [Full Text] [Related]
13. Synthesis, anticancer activity, molecular docking and molecular dynamics studies of some pyrazole-chalcone hybrids.
Al Otaibi AA; Alshammari SL; Dhahi Alsukaibi AK; Jamal A; Rajendrasozhan S; Alenezi KM; Hussain A; Khan I; Mushtaque M; Haque A
J Biomol Struct Dyn; 2024; 42(3):1381-1391. PubMed ID: 37071766
[TBL] [Abstract] [Full Text] [Related]
14. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract] [Full Text] [Related]
15. Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive lung cancers.
Rotow J; Patel JD; Hanley MP; Yu H; Awad M; Goldman JW; Nechushtan H; Scheffler M; Kuo CS; Rajappa S; Harada G; Clifford S; Santucci A; Silva L; Tupper R; Oxnard GR; Kherani J; Drilon A
Clin Cancer Res; 2023 Aug; 29(16):2979-2987. PubMed ID: 36996322
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell lung cancer Patients Treated with Immune Checkpoint Inhibitors.
Genova C; Tasso R; Rosa A; Rossi G; Reverberi D; Fontana V; Marconi S; Croce M; Dal Bello MG; Dellepiane C; Tagliamento M; Ciferri MC; Zullo L; Fedeli A; Alama A; Cortese K; Gentili C; Cella E; Anselmi G; Mora M; Barletta G; Rijavec E; Grossi F; Pronzato P; Coco S
Cells; 2023 Mar; 12(6):. PubMed ID: 36980174
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases.
Chiang CL; Ho HL; Yeh YC; Lee CC; Huang HC; Shen CI; Luo YH; Chen YM; Chiu CH; Chou TY
Thorac Cancer; 2023 May; 14(14):1251-1259. PubMed ID: 36977550
[TBL] [Abstract] [Full Text] [Related]
18. Dynamic Play between Human N-α-acetyltransferase D and H4-mutant Histones: Molecular Dynamics Study.
Rathod SB; Srivastava KR
Curr Protein Pept Sci; 2023; 24(4):339-354. PubMed ID: 36924088
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of 3,5-diaryl-1H-pyrazol-based ureas as potent RET inhibitors.
Wu K; He R; Li Z; Qiu K; Xiao G; Peng L; Meng X; Zheng C; Zhang Z; Cai Q
Eur J Med Chem; 2023 May; 251():115237. PubMed ID: 36905915
[TBL] [Abstract] [Full Text] [Related]
20. "Anti-cancer" effect of ketamine in comparison with MK801 on neuroglioma and lung cancer cells.
Saito J; Zao H; Wu L; Iwasaki M; Sun Q; Hu C; Ishikawa M; Hirota K; Ma D;
Eur J Pharmacol; 2023 Apr; 945():175580. PubMed ID: 36758782
[TBL] [Abstract] [Full Text] [Related]
[Next]
